Formation of R&D consortiums needed to promote domestic R&D new drug projects

There is mounting consensus in domestic pharmaceutical industry that the breakthrough for better competitiveness of Korean pharmaceutical firms in the global arena is to ensure the efficiency of R&D spending through the formation of consortiums, according to pharmaceutical business sources.

The sources said domestic pharmaceutical industry should form R&D consortiums in parallel with the gov...